This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema
skeeze / Pixabay

This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema

According to a story from Angioedema News, the drug development company Regenxbio has announced that it is in the process of developing a new gene therapy treatment for hereditary angioedema,…

Continue Reading This Company is Making Plans to Develop a Gene Therapy for Hereditary Angioedema
This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients
kalhh / Pixabay

This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients

According to a story from Scleroderma News, a recent study has recommended that scleroderma patients with a rare, poorly understood form of interstitial lung disease (ILD) should receive regular monitoring…

Continue Reading This Form of Rare Interstitial Lung Disease is Bad News for Scleroderma Patients

First Patient Enrolled in Pediatric Tourette’s Syndrome Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company Emalex Biosciences, Inc., has recently announced that the very first patient has been signed up for the company's phase 2b clinical…

Continue Reading First Patient Enrolled in Pediatric Tourette’s Syndrome Clinical Trial

ICYMI: Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects

According to a publication from EurekAlert, a recent study helmed by the Royal Marsden NHS Foundation Trust suggests that female cancer patients tend to live slightly longer following treatment than…

Continue Reading ICYMI: Study Suggests Female Cancer Patients Have Better Outcomes After Treatment, Experience Worse Side Effects
Close Menu